Rise Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-507
| Closed | -$30K | – | 656 |
|
|
2023
Q3 | $30K | Hold |
507
| – | – | 0.02% | 188 |
|
|
2023
Q2 | $30.3K | Hold |
507
| – | – | 0.02% | 197 |
|
|
2023
Q1 | $29.6K | Buy |
507
+3
| +0.6% | +$175 | 0.02% | 207 |
|
|
2022
Q4 | $31.3K | Buy |
504
+3
| +0.6% | +$186 | 0.03% | 197 |
|
|
2022
Q3 | $28K | Sell |
501
-156
| -24% | -$8.72K | 0.02% | 212 |
|
|
2022
Q2 | $42K | Buy |
657
+3
| +0.5% | +$192 | 0.04% | 157 |
|
|
2022
Q1 | $42K | Buy |
654
+3
| +0.5% | +$193 | 0.04% | 163 |
|
|
2021
Q4 | $43.3K | Buy |
+651
| New | +$43.3K | 0.04% | 162 |
|